Diagnostic Workup for Secondary Amenorrhea
Initial Assessment
- The American College of Obstetricians and Gynecologists recommends performing a pregnancy test as the first step in evaluation, as pregnancy is the most common cause of missed menses 1, 2
- Recent weight loss or low BMI can trigger functional hypothalamic amenorrhea (FHA) 3, 2
- Excessive exercise patterns can contribute to FHA 3, 2
- Psychological stress can be a factor in the development of FHA 3, 2
- Caloric restriction or energy deficit can lead to FHA 3, 2
Laboratory Evaluation
- Measuring serum FSH and LH levels can help differentiate between hypothalamic-pituitary causes and ovarian causes 2, 4
- A low/normal FSH and LH level suggests hypothalamic amenorrhea 4
- An LH:FSH ratio >2 suggests polycystic ovary syndrome (PCOS) 4
- Checking serum prolactin levels can help rule out hyperprolactinemia, which accounts for approximately 20% of secondary amenorrhea cases 2
- Evaluating thyroid function with TSH measurement is essential in the diagnostic workup 2
Imaging and Additional Testing
- Performing a pelvic ultrasound can help evaluate for polycystic ovarian morphology (PCOM) and uterine abnormalities 3, 4
- PCOM is defined as ≥20 follicles of 2-9mm per ovary or ovarian volume >10ml 3, 4
Differential Diagnosis
- Functional hypothalamic amenorrhea (FHA) is characterized by low/normal gonadotropins, negative progestin challenge, and identifiable stressors 3, 2
- Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, oligo/anovulation, and often polycystic ovaries on ultrasound 2
- FHA-PCOM is a special entity where patients have features of both FHA and PCOM, affecting approximately 40-47% of women with FHA 5, 2
Management Considerations
- Addressing underlying causes such as weight restoration, stress reduction, and decreased exercise intensity is essential in the management of FHA 3, 2
- Considering hormone replacement therapy to prevent bone loss and other consequences of hypoestrogenism is recommended for FHA patients 2
- For PCOS, considering cyclic progesterone to induce regular withdrawal bleeding and addressing metabolic risks with lifestyle modifications is crucial 2
Follow-Up and Monitoring
- Monitoring bone mineral density in patients with prolonged hypoestrogenic states is essential 2
- Regular assessment of menstrual patterns to evaluate treatment response is necessary 2